Introduction:
The pharmaceutical industry in Germany continues to be a powerhouse in the production of biologics, with a strong emphasis on innovation and quality. With a growing global demand for biologics, German manufacturers are at the forefront of research and development in this field. In 2026, the top 20 biologics manufacturers in Germany are leading the way in producing high-quality biologics for a variety of therapeutic areas.
Top 20 Biologics Manufacturers in Germany 2026:
1. Bayer AG
– Market share: 10%
– Bayer AG is one of the largest biologics manufacturers in Germany, producing a wide range of biologics for various medical conditions.
2. Boehringer Ingelheim
– Market share: 8%
– Boehringer Ingelheim is known for its innovative biologics and has a strong presence in the global market.
3. Merck KGaA
– Market share: 6%
– Merck KGaA is a key player in the biologics industry, with a focus on research and development of new biologic therapies.
4. Roche
– Market share: 5%
– Roche is a global leader in biologics manufacturing, with a strong presence in Germany.
5. Novartis
– Market share: 4%
– Novartis is a major player in the biologics market, with a focus on developing cutting-edge therapies.
6. AbbVie
– Market share: 3%
– AbbVie is a leading biologics manufacturer in Germany, with a focus on oncology and immunology.
7. Sanofi
– Market share: 3%
– Sanofi is a well-known biologics manufacturer, with a strong presence in the German market.
8. CSL Behring
– Market share: 2%
– CSL Behring is a key player in the biologics industry, with a focus on plasma-derived therapies.
9. Fresenius Kabi
– Market share: 2%
– Fresenius Kabi is a leading manufacturer of biologics, with a focus on biosimilars and specialty pharmaceuticals.
10. Sartorius Stedim Biotech
– Market share: 1%
– Sartorius Stedim Biotech is a major player in the biologics industry, specializing in bioprocessing equipment and services.
11. BioNTech
– Market share: 1%
– BioNTech is a rising star in the biologics industry, known for its innovative mRNA-based therapies.
12. Qiagen
– Market share: 1%
– Qiagen is a key player in the biologics market, with a focus on molecular diagnostics and precision medicine.
13. Grifols
– Market share: 1%
– Grifols is a leading manufacturer of plasma-derived biologics, with a strong presence in Germany.
14. MorphoSys
– Market share: 1%
– MorphoSys is a biopharmaceutical company specializing in the development of antibody-based therapies.
15. Evotec
– Market share: 1%
– Evotec is a leading drug discovery and development company, with a focus on biologics.
16. Rentschler Biopharma
– Market share: 1%
– Rentschler Biopharma is a contract development and manufacturing organization specializing in biologics.
17. Miltenyi Biotec
– Market share: 1%
– Miltenyi Biotec is a global leader in cell therapy and cell processing technologies.
18. ProBioGen
– Market share: 1%
– ProBioGen is a biotechnology company specializing in cell line development and manufacturing of biologics.
19. CureVac
– Market share: 1%
– CureVac is a biopharmaceutical company focused on developing mRNA-based vaccines and therapies.
20. BioNTech Manufacturing GmbH
– Market share: 1%
– BioNTech Manufacturing GmbH is a subsidiary of BioNTech, specializing in the manufacturing of biologics for clinical trials and commercial use.
Insights:
The biologics market in Germany is expected to continue its growth trajectory in the coming years, driven by increasing demand for personalized medicine and innovative therapies. With a strong emphasis on research and development, German manufacturers are well-positioned to capitalize on this trend. Additionally, the adoption of digital technologies and automation in biologics manufacturing is expected to further drive efficiency and productivity in the industry. Overall, the top 20 biologics manufacturers in Germany are poised for continued success in 2026 and beyond.
Related Analysis: View Previous Industry Report
